Vivian Laquer

Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis

Shawn G. Kwatra, Gil Yosipovitch, Franz J. Legat et al. · New England Journal of Medicine · 2023 · 135 citations · Full text

Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial

Andrew Blauvelt, Richard G. Langley, J.‐P. Lacour et al. · Journal of the American Academy of Dermatology · 2022 · 70 citations · Full text

Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials

Linda Stein Gold, Diamant Thaçi, Jacob P. Thyssen et al. · American Journal of Clinical Dermatology · 2023 · 60 citations · Full text

Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study

Jonathan I. Silverberg, Andreas Pinter, Afsáneh Alavi et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 56 citations · Full text

A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results

Nina Magnolo, Külli Kingo, Vivian Laquer et al. · Journal of the American Academy of Dermatology · 2021 · 47 citations

Inflammation, Medicine, Pediatric Patients +7